Skip to main content
Download PDF
- Main
Nondisclosure of HIV Status in a Clinical Trial Setting: Antiretroviral Drug Screening Can Help Distinguish Between Newly Diagnosed and Previously Diagnosed HIV Infection
- Marzinke, Mark A;
- Clarke, William;
- Wang, Lei;
- Cummings, Vanessa;
- Liu, Ting-Yuan;
- Piwowar-Manning, Estelle;
- Breaud, Autumn;
- Griffith, Sam;
- Buchbinder, Susan;
- Shoptaw, Steven;
- del Rio, Carlos;
- Magnus, Manya;
- Mannheimer, Sharon;
- Fields, Sheldon D;
- Mayer, Kenneth H;
- Wheeler, Darrell P;
- Koblin, Beryl A;
- Eshleman, Susan H;
- Fogel, Jessica M
- et al.
Published Web Location
https://doi.org/10.1093/cid/cit672Abstract
In The HIV Prevention Trials Network 061 study, 155 human immunodeficiency virus (HIV)-infected men reported no prior HIV diagnosis; 83 of those men had HIV RNA levels of <1000 copies/mL at enrollment. Antiretroviral drug testing revealed that 65 of the 83 (78.3%) men were on antiretroviral treatment. Antiretroviral drug testing can help distinguish between newly diagnosed and previously diagnosed HIV infection.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.
Main Content
For improved accessibility of PDF content, download the file to your device.
Enter the password to open this PDF file:
File name:
-
File size:
-
Title:
-
Author:
-
Subject:
-
Keywords:
-
Creation Date:
-
Modification Date:
-
Creator:
-
PDF Producer:
-
PDF Version:
-
Page Count:
-
Page Size:
-
Fast Web View:
-
Preparing document for printing…
0%